ISRCTN54451987已完成未知
A randomised controlled clinical trial of the comparison of two strategies (multifaceted strategy multi-pronged strategy of individualized attention versus a self-control strategy) for the management of patients with COPD and/or heart failure
niversity Hospital Donostia (Hospital Universitario Donostia) (Spain)0 个研究点目标入组 230 人开始时间: 2012年7月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 230
研究概览
简要总结
- 2018 results in http://dx.doi.org/10.5750/ejpch.v6i4.1538 (added 22/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with heart failure stage II-IV New York Heart Association (NYHA)
- •2. Patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) from any cause and with one or more hospital admissions in the previous year for the same condition.
- •3. Patients with heart failure stage II-IV of NYHA and COPD to present more than two severe comorbidities that want to participate.
- •4. Patients who own a computer with internet access and management practice
排除标准
- •1. Patients with moderate or severe dementia
- •2. Patients with impaired mobility that prevents them from performing aerobic exercise
- •3. Patients who refuses to participate
研究者
相似试验
已完成
1 期
A Clinical Trial of CS12192 in Healthy SubjectsHealthyNCT05922709Chipscreen Biosciences, Ltd.108
已完成
1 期
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 CapsulesHealthyNCT06224595Chipscreen Biosciences, Ltd.112
已完成
1 期
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).Wilson's DiseaseNCT06128954Orphalan26
已完成
1 期
A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)ObesityNCT06279234Pfizer50
已完成
1 期
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese MenCoronary Artery DiseaseNCT03400488AstraZeneca32
